Functional Assessment in Liver Transplantation
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Jul 19, 2017
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Functional Assessment in Liver Transplantation," is studying how liver disease affects patients' everyday abilities and overall quality of life. Researchers will assess participants' strength, mobility, and daily functioning both before and after liver transplantation. This means that if you join the study, you will answer questions about how you feel and how well you can do daily activities. These assessments will happen regularly during your doctor visits, starting before the transplant and continuing up to a year after the procedure, with follow-ups each year after that.
To be eligible for this trial, you need to be an adult aged 18 or older who is receiving treatment for liver disease. The study is currently recruiting participants of all genders, and it aims to gather important information that may help improve care for patients with end-stage liver disease in the future. If you decide to participate, you can expect to have regular check-ins that look at how well you're doing physically and mentally, which can help doctors understand the best ways to support patients like you.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (≥18 years old)
- • Are seen for the treatment of liver disease
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Ann Arbor, Michigan, United States
Durham, North Carolina, United States
New York, New York, United States
Seattle, Washington, United States
San Francisco, California, United States
Little Rock, Arkansas, United States
Indianapolis, Indiana, United States
Loma Linda, California, United States
Baltimore, Maryland, United States
Pittsburgh, Pennsylvania, United States
Dallas, Texas, United States
Patients applied
Trial Officials
Jennifer C Lai, MD, MBA
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials